Trial intelligence / Profile preview

Pyrotinib after standard trastuzumab adjuvant therapy in HER2-positive early or locally advanced breast cancer

ChiCTR2200060726Phase 4Not yet recruiting

Sponsor

Baotou Tumor Hospital

Start

May 2022

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1